6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Kemurnian ≥98,0% (HPLC) Favipiravir Intermediate COVID-19

Katrangan singkat:

Jeneng Kimia: 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

CAS: 356783-31-8

Penampilan: Kuning pucet nganti bubuk putih

Kemurnian: ≥98,0% (HPLC)

Intermediate of Favipiravir (CAS: 259793-96-9) ing perawatan infeksi virus Influenza lan COVID-19

Kualitas Tinggi, Produksi Komersial

Inquiry: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Produsen kanthi Kemurnian Tinggi lan Kualitas Stabil
Favipiravir Pasokan Komersial lan Perantara sing Gegandhengan:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Sifat Kimia:

Jeneng Kimia	6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
sinonim	6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
Nomer CAS	356783-31-8
Nomer CAT	RF-API294
Status Simpenan	Ing Stok, Skala Produksi Nganti Atusan Kilogram
Formula Molekul	C5H2FN3O
Bobot Molekul	139.09
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Kuning pucet nganti bubuk putih
Identifikasi	IR, HPLC
Kelembapan (KF)	≤1,0%
Sisa ing Ignition	≤0,50%
Impurity Tunggal	≤1,0%
Total Impurities	≤2,0%
Logam abot	≤20ppm
Kemurnian	≥98,0% (dening HPLC)
Test Standar	Standar Perusahaan
Panggunaan	Intermediate Favipiravir (CAS 259793-96-9);Antivirus;COVID 19

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.

Kaluwihan:

FAQ:

Aplikasi:

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) minangka Intermediate Favipiravir (CAS 259793-96-9).Favipiravir minangka obat antivirus spektrum luas anyar sing nargetake RNA-dependent RNA polymerase (RdRp).Favipiravir wiwitane dikembangake ing pungkasan taun 1990-an dening perusahaan sing banjur dituku dening perusahaan Jepang Fujifilm minangka bagéan saka transisi saka bisnis foto menyang perawatan kesehatan.Sawise dites nglawan macem-macem virus, obat kasebut disetujoni ing Jepang ing taun 2014 kanggo panggunaan darurat nglawan epidemi flu utawa kanggo nambani galur influenza anyar.Sajrone wabah koronavirus anyar, asil panaliten klinis Fase I obat sing diterbitake ing Maret 2020 nuduhake manawa obat kasebut bisa uga duwe efek nyepetake reresik virus kanggo nyuda kemajuan pneumonia koronavirus anyar.Favipiravir bisa digunakake kanggo perawatan pasien COVID-19 sing disaranake WHO.Iki diresiki dening Pengontrol Obat Umum India (DCGI) kanggo panggunaan "diwatesi darurat" ing antarane pasien COVID-19.